pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-449b |
Genomic Coordinates | chr5: 55170646 - 55170742 |
Description | Homo sapiens miR-449b stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-449b-5p | ||||||||||||||||||
Sequence | 16| AGGCAGUGUAUUGUUAGCUGGC |37 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Microarray | DRVs in miRNA |
|
||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | MFSD8 | ||||||||||||||||||||
Synonyms | CCMD, CLN7 | ||||||||||||||||||||
Description | major facilitator superfamily domain containing 8 | ||||||||||||||||||||
Transcript | NM_152778 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on MFSD8 | |||||||||||||||||||||
3'UTR of MFSD8 (miRNA target sites are highlighted) |
>MFSD8|NM_152778|3'UTR 1 ACTAGCTAAGACTGTGATGGAAACTACTTGCTGTGTGGCACTTCCTGGTCTAAAGCTCTGCTAGACAATTGCGGTGAGCC 81 AGTCTCCAAGAATCAGACTACAGATATTGCAGATTTTGAAGAACAAGAACATATGTTGAATAACAGAGAGAATTCTACAT 161 GTCATTGTGAATAGTAGGTTATATAAAAACATACTAGATGATAATTTCCTTACCTCAGAAATGAAATATTATTCTTATAA 241 TACCTTTTTGTGGTTGCATGAACTAATGAGTGAATGGACAATGATGAATAAATGTGAAGCTGTATTCTTAATACCCACTG 321 CAGAAGTGTCATTAAAATAATATACAGTGGAACCAGAAAGAGGGTTCTGTAAGAATTAGCCATAGCAGAACAAAATTATA 401 GAATTTTAAATACCTCTACCCAAGTAGAGGTATTTTTATTCAGACACCTACTTTTTATTTATAAAAAAATGCATTTTCTA 481 TTATCAAGTTCACTTATGAAATAAAAATTATAACACATATTTTCCATTTAGCGTGCCTAACATCCTACCTTGCCTTCTAT 561 GAGTCTTTCTTCTAATACTACACCTCTGCCTTATTTTAGTTCAGGGTTTCACTAAGTAACCCCTACATTAATAAATGAGT 641 ATGGATAATGCTAATATTTGAGCAATACAGAGGATTAAGAGATCAAGATACTTCACTGCCTATTAGCCTAATAGGGATAC 721 CTACTTTCTTTCAAATGCCAAAAATTCACATTAGAAACATAATCCAGATATGTGTTATTTTATATATATATATACAAAAC 801 AGTAAATGGTTTCTTAAAATTATTGCTATTTTTCAACCCCCTTAAACTGGAGAAAAACATTTAATTAGTAAAACATTAAT 881 TAATTTACTTTAATTTTTCCCATCTCTCAGTAGTGGCGGGGAGGAACACAACAGTTTTCAATCTATGTCTGCATAGTTGT 961 GTAGAGCTGCAGAATTTTAGTTGGATTTTTAATTTGGATGATCCCTGACAGCCCCAAACTAGTCAGGCTAATAAGTATTT 1041 GAGGCAAAATGGCTTTAATCTAACAATTTACTGAGTTTACCTGAAGTTGGCTAAATAACACTGTATGTTTAACTTCTACC 1121 TCTACATAAGTTGAATGCTGATAAAAGGAACTAGTAGATAACTATGTATATTGATAAGCACTGTTAAGAAAATGCAAAAA 1201 TATTTCTAAACACTTTTCCAAATGTTTTCTACTTTAAGTTAGAAATAGTTTCAAATCTGAGAATAAACACTATATAATCT 1281 GCACTTTATAGGTTGGGTGCAGTGTCTCATGCCTGTAATCCCAGCACTTTGGAAGGCCAAGGCAGGAGGATTGCTTGAGG 1361 CCAGGAATTCAAGACCAGCCTGGGAAACAAAGTGAGACCCTGTCTTTACAAAAAATAAAAACAAAAATTTAAAACTGTAT 1441 AATCTGCACTTTATGCTAAACTAGCTGTGCTCTTAAACTCAATTTTTTCAGCTCTAATAAAGGGCTTAATTTGATAGAAT 1521 TATTCTACGATTAAATTTTGAAGACTGTTTTCACTCTCCTCTGCCGCCCATAGCAAGACTGCTTCCATAGATTTCTCAGA 1601 ACCGTAGCCAGTTCTGGCTATTTGGTCAAGTCTGGGATCCCTCTTACCTGCTATTCTGCAGCTGCTTTCTCTGTCTTACA 1681 TTTTTTGGGCCACGTCTAATCTTAAAGAGTAAACTCTACCCTTGGTTTGCATAGTGTGCATGACAAAAATAACAAGAATA 1761 ATGGTAATGATGAAAATGATAAGAGCAAAATTTGTGGAGTGCTTTCCACATTCCAGGTAATGTGTAACATACAATTTAAT 1841 TCTTACAGCAGTCTTATGGAGTGAAAATACTATTATGATTCCCGTTTTACAGATGAAAGAATGGAGGCACAGAAAAGTTA 1921 CTTGTCTAAGTAACAGTCTATCCTTAAAGTCCACAGTCTTAACCACTTGATTTTTCATAGTGAGGAAAATATCCCAGAAA 2001 GTTGCAGTTTCAATTAATCACTAATTGTAGGGTAATTTAACTATACCAGTGAGTCCTACTAGCAGAAATATTTGGGCAAC 2081 ATAAGCCCACTGACTGGAGCTTTTGTCTTAGCATAATAACCTGTTTCCAGCAAGAATATAACAGAAAAAAGTTTCCCAGC 2161 TTTCAAAGGTTTATAATATTGATTAAAATTTAGATAAACTTAACCTTACACAAATGACTCTTACTTTCCTTTTTATTGAG 2241 AGCATTTTCTTTGGAGCATTTTCTTCTTTGGAGGATTATACCTTGCTCATCTTGGCACAAAAGAAGGCGAAAGGAAGTAA 2321 CATGGGATTGGGAAAAGAGCAAGGAGATAAAGTTTGAGGAAAAAAAATCACCATGTTGATGTCTTCTTGAGTAGGCCAAG 2401 TTGCGTATAAAGAGAAAATGACAACAGGAGATTTTAAGGTATGATATATTGTTAAGAGTAGTACATATTTAAGAAGAGAA 2481 AATATGTTTTTGAAAACAAATTTAAACTTGAAAGGATGATTTTCATATTTTGAAGGGATTTATAACTTCACAAAGCATCT 2561 CCATTCTATCTTGTTCAGCTTTACATTTAAAAATAAACTCTTCTTGTTCATATAAACCTTATCTCTTACATAAAGTGAAA 2641 TCTGTTAATTTTTTGTTTTGACAAGGATAAACTACTTACCTGCATCTGTTTAAGAATAGATTAACTTATTTTGAGAAGAA 2721 ATTCTGGGCACCATTTTTGACCATTGAAGACTTATTTGTAATTTAATTTCTACTTTACATTGTGAATGTTCATTTTCTAA 2801 TAAACAAGATTATTTTGCATATGTAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | BC-1 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796038. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
CLIP-seq Support 1 for dataset GSM796038 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-1 / 4-Thiouridine |
Location of target site | ENST00000296468.3 | 3UTR | UCAAGAUACUUCACUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
109 hsa-miR-449b-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT006349 | SIRT1 | sirtuin 1 | 2 | 1 | ||||||||
MIRT006350 | CCNE2 | cyclin E2 | 4 | 3 | ||||||||
MIRT006351 | MET | MET proto-oncogene, receptor tyrosine kinase | 2 | 1 | ||||||||
MIRT006352 | GMNN | geminin, DNA replication inhibitor | 2 | 1 | ||||||||
MIRT006353 | HDAC1 | histone deacetylase 1 | 2 | 1 | ||||||||
MIRT016137 | CDK4 | cyclin dependent kinase 4 | 1 | 1 | ||||||||
MIRT016138 | CDC25A | cell division cycle 25A | 2 | 1 | ||||||||
MIRT016139 | CDK6 | cyclin dependent kinase 6 | 4 | 3 | ||||||||
MIRT057740 | ZDHHC16 | zinc finger DHHC-type containing 16 | 2 | 2 | ||||||||
MIRT078636 | FAM104A | family with sequence similarity 104 member A | 2 | 2 | ||||||||
MIRT100407 | HSPA1B | heat shock protein family A (Hsp70) member 1B | 2 | 2 | ||||||||
MIRT115552 | MAZ | MYC associated zinc finger protein | 2 | 2 | ||||||||
MIRT130146 | TXNIP | thioredoxin interacting protein | 2 | 4 | ||||||||
MIRT142254 | DCTN5 | dynactin subunit 5 | 2 | 2 | ||||||||
MIRT143724 | CCL22 | C-C motif chemokine ligand 22 | 2 | 2 | ||||||||
MIRT168101 | E2F3 | E2F transcription factor 3 | 2 | 2 | ||||||||
MIRT169809 | GIGYF1 | GRB10 interacting GYF protein 1 | 2 | 4 | ||||||||
MIRT183694 | MDM4 | MDM4, p53 regulator | 2 | 2 | ||||||||
MIRT198922 | SMAD4 | SMAD family member 4 | 2 | 2 | ||||||||
MIRT202950 | TSN | translin | 2 | 4 | ||||||||
MIRT221565 | CBX3 | chromobox 3 | 2 | 2 | ||||||||
MIRT253418 | EVI5L | ecotropic viral integration site 5 like | 2 | 2 | ||||||||
MIRT294759 | ZNF551 | zinc finger protein 551 | 2 | 4 | ||||||||
MIRT307053 | TGFBR2 | transforming growth factor beta receptor 2 | 2 | 2 | ||||||||
MIRT331273 | TM9SF3 | transmembrane 9 superfamily member 3 | 2 | 6 | ||||||||
MIRT372293 | UBXN2B | UBX domain protein 2B | 2 | 2 | ||||||||
MIRT374317 | MBD6 | methyl-CpG binding domain protein 6 | 2 | 2 | ||||||||
MIRT445817 | DNAAF3 | dynein axonemal assembly factor 3 | 2 | 2 | ||||||||
MIRT447158 | MFSD8 | major facilitator superfamily domain containing 8 | 2 | 2 | ||||||||
MIRT447823 | CTIF | cap binding complex dependent translation initiation factor | 2 | 2 | ||||||||
MIRT448798 | GMFB | glia maturation factor beta | 2 | 2 | ||||||||
MIRT451580 | HIRIP3 | HIRA interacting protein 3 | 2 | 2 | ||||||||
MIRT452679 | GPR156 | G protein-coupled receptor 156 | 2 | 2 | ||||||||
MIRT453158 | CNOT4 | CCR4-NOT transcription complex subunit 4 | 2 | 6 | ||||||||
MIRT453634 | SLC4A2 | solute carrier family 4 member 2 | 2 | 2 | ||||||||
MIRT455384 | PLA2G2D | phospholipase A2 group IID | 2 | 2 | ||||||||
MIRT456958 | SPAM1 | sperm adhesion molecule 1 | 2 | 2 | ||||||||
MIRT462739 | EFNB1 | ephrin B1 | 2 | 2 | ||||||||
MIRT464321 | UST | uronyl 2-sulfotransferase | 2 | 2 | ||||||||
MIRT465641 | TNRC18P2 | trinucleotide repeat containing 18 pseudogene 2 | 2 | 10 | ||||||||
MIRT466748 | SYNGR2 | synaptogyrin 2 | 2 | 2 | ||||||||
MIRT468345 | SF3B3 | splicing factor 3b subunit 3 | 2 | 2 | ||||||||
MIRT469324 | RGP1 | RGP1 homolog, RAB6A GEF complex partner 1 | 2 | 2 | ||||||||
MIRT474361 | KMT2D | lysine methyltransferase 2D | 2 | 2 | ||||||||
MIRT475316 | IFNLR1 | interferon lambda receptor 1 | 2 | 2 | ||||||||
MIRT477759 | EDEM3 | ER degradation enhancing alpha-mannosidase like protein 3 | 2 | 2 | ||||||||
MIRT477824 | DYRK3 | dual specificity tyrosine phosphorylation regulated kinase 3 | 2 | 2 | ||||||||
MIRT478265 | DDX19B | DEAD-box helicase 19B | 2 | 2 | ||||||||
MIRT481042 | BAZ2A | bromodomain adjacent to zinc finger domain 2A | 2 | 2 | ||||||||
MIRT481289 | ATXN1L | ataxin 1 like | 2 | 2 | ||||||||
MIRT482730 | COPZ1 | coatomer protein complex subunit zeta 1 | 2 | 2 | ||||||||
MIRT488780 | CYTH3 | cytohesin 3 | 2 | 2 | ||||||||
MIRT489578 | SSBP2 | single stranded DNA binding protein 2 | 2 | 2 | ||||||||
MIRT489659 | SHMT1 | serine hydroxymethyltransferase 1 | 2 | 4 | ||||||||
MIRT490527 | KIAA1715 | lunapark, ER junction formation factor | 2 | 2 | ||||||||
MIRT492949 | NEUROD2 | neuronal differentiation 2 | 2 | 2 | ||||||||
MIRT493154 | MKNK2 | MAP kinase interacting serine/threonine kinase 2 | 2 | 2 | ||||||||
MIRT493845 | FOXN3 | forkhead box N3 | 2 | 4 | ||||||||
MIRT494743 | ARHGAP1 | Rho GTPase activating protein 1 | 2 | 6 | ||||||||
MIRT496491 | MAST3 | microtubule associated serine/threonine kinase 3 | 2 | 2 | ||||||||
MIRT503312 | FICD | FIC domain containing | 2 | 4 | ||||||||
MIRT503507 | ZNF623 | zinc finger protein 623 | 2 | 2 | ||||||||
MIRT504182 | FAM127B | retrotransposon Gag like 8A | 2 | 2 | ||||||||
MIRT505010 | ZNF644 | zinc finger protein 644 | 2 | 2 | ||||||||
MIRT505352 | TMEM167A | transmembrane protein 167A | 2 | 2 | ||||||||
MIRT505645 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | 2 | 2 | ||||||||
MIRT505710 | SESN2 | sestrin 2 | 2 | 2 | ||||||||
MIRT505777 | SATB2 | SATB homeobox 2 | 2 | 6 | ||||||||
MIRT506208 | PHF19 | PHD finger protein 19 | 2 | 2 | ||||||||
MIRT506251 | PEG10 | paternally expressed 10 | 2 | 2 | ||||||||
MIRT507786 | CDKN1B | cyclin dependent kinase inhibitor 1B | 2 | 2 | ||||||||
MIRT508005 | BCL2L13 | BCL2 like 13 | 2 | 4 | ||||||||
MIRT508857 | ZRSR1 | zinc finger CCCH-type, RNA binding motif and serine/arginine rich 1 | 2 | 4 | ||||||||
MIRT510546 | XBP1P1 | X-box binding protein 1 pseudogene 1 | 2 | 4 | ||||||||
MIRT511892 | GAS1 | growth arrest specific 1 | 2 | 6 | ||||||||
MIRT512907 | UBL4A | ubiquitin like 4A | 2 | 2 | ||||||||
MIRT513600 | VPS37B | VPS37B, ESCRT-I subunit | 2 | 2 | ||||||||
MIRT521241 | SAR1A | secretion associated Ras related GTPase 1A | 2 | 2 | ||||||||
MIRT521321 | RRAGD | Ras related GTP binding D | 2 | 4 | ||||||||
MIRT525281 | C18orf32 | chromosome 18 open reading frame 32 | 2 | 2 | ||||||||
MIRT528650 | RWDD2A | RWD domain containing 2A | 2 | 4 | ||||||||
MIRT535101 | PODXL | podocalyxin like | 2 | 2 | ||||||||
MIRT547752 | KBTBD6 | kelch repeat and BTB domain containing 6 | 2 | 4 | ||||||||
MIRT547865 | HSPA13 | heat shock protein family A (Hsp70) member 13 | 2 | 2 | ||||||||
MIRT549170 | BMP3 | bone morphogenetic protein 3 | 2 | 2 | ||||||||
MIRT550115 | SLC35G2 | solute carrier family 35 member G2 | 2 | 2 | ||||||||
MIRT556097 | MOAP1 | modulator of apoptosis 1 | 2 | 2 | ||||||||
MIRT557172 | HOXA13 | homeobox A13 | 2 | 2 | ||||||||
MIRT557422 | GXYLT2 | glucoside xylosyltransferase 2 | 2 | 2 | ||||||||
MIRT557931 | FAM73A | mitoguardin 1 | 2 | 2 | ||||||||
MIRT568804 | VPS37D | VPS37D, ESCRT-I subunit | 2 | 2 | ||||||||
MIRT571326 | TPCN2 | two pore segment channel 2 | 2 | 2 | ||||||||
MIRT572598 | PAPLN | papilin, proteoglycan like sulfated glycoprotein | 2 | 2 | ||||||||
MIRT573437 | APOPT1 | apoptogenic 1, mitochondrial | 2 | 2 | ||||||||
MIRT574092 | VASN | vasorin | 2 | 2 | ||||||||
MIRT608688 | VAV3 | vav guanine nucleotide exchange factor 3 | 2 | 4 | ||||||||
MIRT608800 | ITGA11 | integrin subunit alpha 11 | 2 | 4 | ||||||||
MIRT610332 | SSX5 | SSX family member 5 | 2 | 2 | ||||||||
MIRT613158 | DDA1 | DET1 and DDB1 associated 1 | 2 | 2 | ||||||||
MIRT625407 | CPEB3 | cytoplasmic polyadenylation element binding protein 3 | 2 | 2 | ||||||||
MIRT636603 | CLIC5 | chloride intracellular channel 5 | 2 | 2 | ||||||||
MIRT638573 | IER5 | immediate early response 5 | 2 | 2 | ||||||||
MIRT639686 | AASDHPPT | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 2 | 2 | ||||||||
MIRT677979 | ITGB3 | integrin subunit beta 3 | 2 | 2 | ||||||||
MIRT685217 | POTED | POTE ankyrin domain family member D | 2 | 2 | ||||||||
MIRT702570 | JARID2 | jumonji and AT-rich interaction domain containing 2 | 2 | 2 | ||||||||
MIRT706259 | MKLN1 | muskelin 1 | 2 | 2 | ||||||||
MIRT734675 | HMGB1 | high mobility group box 1 | 3 | 0 | ||||||||
MIRT736369 | HSPA1A | heat shock protein family A (Hsp70) member 1A | 1 | 0 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|